CGI Group (GIB) Stock Forecast & Price Target

CGI is attractive fundamentally because its revenue base is anchored in stickier end markets like government, financials, and healthcare, where long-duration relationships and mission-critical IT spending support resilience, while its proximity-based global delivery model across 40+ countries and 90,000+ professionals reinforces competitive differentiation and execution capacity. CGI is also well positioned financially, with management and analysts highlighting a strong balance sheet, consistent free cash flow of more than an 11% yield, and an active buyback and disciplined M&A approach that has historically enhanced scale and earnings durability, even as the company continues to embed AI across nearly 200 agents and 400 workflows to improve service productivity and margins. CGI is, however, priced with some caution around slower organic growth and AI disruption, but the case for a positive outlook rests on its faster NTM adjusted EPS growth of 9% versus peers at 3%, industry-leading margins, and valuation that remains below historical norms despite a solid operating backdrop and improving bookings potential.

CGI is facing a weaker fundamental setup because its organic growth has flattened, with Q2 organic growth at -3.0% versus expectations of -0.9%, seven negative organic growth quarters over the last 10 quarters, and revised estimates of -2.3% FY26e and 0.9% FY27e reflecting intensifying AI-related pricing deflation and substitution risk. The company’s valuation also looks vulnerable, as it trades at 9.6x NTM P/E and 6.5x NTM EBITDA—both near trough or low-end levels relative to its own history and below Accenture’s 5.4x NTM EBITDA inversion narrative—suggesting the market is already embedding a prolonged slowdown in pricing and growth. While CGI still benefits from a defensive revenue mix with Government, Financial Services, and Health contributing over 70% of revenue and levered free cashflow of $2.10B on a TTM basis, its lower organic growth could reduce long-term EPS expansion from above-market to merely in line or below market, limiting the ability of buybacks and acquisitions to improve sentiment.